Figure 1.
Change in weekly AAPS at trough, peak, and evening trough olorinab plasma concentrations. Mean change over time in weekly AAPS measured at trough (predose), peak (1.5 hours postdose), and evening trough (predose) olorinab plasma concentrations in the 25-mg (A) and 100-mg (B) TID dose groups. Summary of mean change from baseline in AAPS at weeks 4 and 8 in the olorinab 25- and 100-mg TID dose groups (C). aFor evening trough at week 2, n = 7 for mean weekly AAPS. *P < 0.05; **P < 0.01 vs baseline. BL, baseline.